Cite
HARVARD Citation
Maggiolo, F. et al. (2023). Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96‐week, phase 3b, open‐label, switch trial in virologically suppressed people ≥65 years of age. HIV medicine. 24 (1), pp. 27-36. [Online].